NABR begrüßt die Entscheidung der IUCN, den Status der Langschwanzmakaken neu zu bewerten

National Association for Biomedical Research Israel Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe District of Columbia

immunologie

6  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808758/#:~:text=Außerdem%2C%20NHP%20entwickeln%20natürlich%20Krebs,und%20Patienten%20mit%20menschlichem%20Krebs . Krebsforschung/Therapien

7 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886327/ Verhaltenspharmakologie

8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402317/ COVID 19 Impfstoffentwicklung

Kontakt: Eva Maciejewski
[e-mail]
[phone]

Logo - https://mma.prnewswire.com/media/1138543/4779677/NABR_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/nabr-begruWt-die-entscheidung-der-iucn-den-status-der-langschwanzmakaken-neu-zu-bewerten-302182381.html